The only oncology platform where AI predictions are mathematically guaranteed to obey biological constraints. No hallucinations. No impossible outcomes.
Watch your multi-omics data transform into physics-constrained predictions
Multi-omics + imaging inputs
Compress to digital twin
Generate physics params
Simulate trajectories
Actionable outputs
Every prediction passes through our Neural ODE layer, which enforces mass conservation and biological rate laws. The math won't let it hallucinate.
A glimpse into the DNAI platform interface
Deep dive into our clinical and biopharma product capabilities

Overview of active patients and system status

Digital twin profile with data completeness

MDM2, CDK4, TP53 drivers with impact scores

Agent-based simulation and immune dynamics

UMAP projections and vector components

Calibration (0.92) and discrimination metrics

Drug scheduling with toxicity constraints

Multi-omics data sources and completeness
Everything you need for precision oncology decision support
RNA, DNA, CNV, methylation, and imaging unified via Product-of-Experts
328-dimensional latent space captures patient biology with disentangled factors
Neural ODEs enforce biological constraints on all trajectory predictions
Patient-specific drug sensitivity scores across targeted, immuno, and chemo
Self-distillation imputes absent modalities probabilistically — predictions degrade gracefully, never fail silently
Three-layer UQ provides confidence intervals that widen with missing data or out-of-distribution patients
Simulate tumor volume changes and predict imaging response classifications
Clone evolution modeling identifies when and how resistance emerges
DNAI is intended for research and pilot deployments. Not approved for clinical decision-making.
Schedule a demo to explore DNAI with your own data.